📰 What This Document Is 📑

This filing is an 8-K report, which is an SEC filing used to announce important, recent corporate events. Essentially, it is a post-quarterly earnings announcement from Intuitive Surgical. The document covers the financial results for the first quarter of 2026 (ending March 31, 2026).

👉 It gives investors a detailed look at how the company performed in Q1 2026, comparing those results directly against the performance of the same time period last year (Q1 2025).

🏥 What Intuitive Surgical Does ⚙️

Intuitive Surgical is a global technology leader that specializes in minimally invasive care. They are known as the pioneer of robotic-assisted surgery, making complex procedures less invasive for patients.

👉 The company's core technologies include the da Vinci surgical systems and the Ion endoluminal system, which help physicians perform advanced surgeries through small incisions. By providing advanced systems, learning platforms, and services, they aim to optimize care delivery and support better patient outcomes.

💰 Q1 2026 Financial Performance 📈

Intuitive reported strong growth in revenue and profitability in the first quarter of 2026. Revenue was $2.77 billion, marking a significant increase of 23% compared to the $2.25 billion reported in the first quarter of 2025.

👉 This strong revenue growth was driven by multiple factors, including rising procedure volumes, increased sales of surgical systems, and a growing installed base of equipment.

Revenue Breakdown

The $2.77 billion revenue was composed of two main segments:

• Instruments and Accessories Revenue: This generated $1.69 billion, an increase of 23% from $1.37 billion in Q1 2025. This portion is highly visible because it covers disposable tools and necessary supplies used during procedures.
• Systems Revenue: This generated $651 million, up from $523 million in Q1 2025. The increase here was due to more da Vinci systems being placed and a higher average selling price for those systems.

Profitability

The company’s profitability also showed significant year-over-year improvement.

• Non-GAAP Net Income: The reported non-GAAP net income was $901 million, which translated to $2.50 per diluted share. This is notably higher than the $662 million (or $1.81 per diluted share) reported in Q1 2025.
• Income from Operations: GAAP income from operations reached $855 million, up from $578 million in Q1 2025.

🧬 Operational Growth Highlights 🎯

The actual use of the surgical systems is the engine driving the company's financial success. Intuitive provided detailed metrics on procedure volumes and system placements, confirming high market adoption.

👉 Overall, worldwide procedures—combining both the da Vinci and Ion systems—grew approximately 17% compared with Q1 2025.

System Adoption Metrics

The company showed robust increases in both its flagship da Vinci system and the Ion endoluminal system.

• Worldwide Procedures: Total procedures grew approximately 17% year-over-year.
  • da Vinci procedures grew approximately 16%.
  • Ion procedures grew impressively by approximately 39%.
• Installed Base: The physical number of systems used in hospitals also grew substantially.
  • The da Vinci installed base grew to 11,395 systems (up 12% from 10,189 in Q1 2025).
  • The Ion installed base grew to 1,041 systems (up 22% from 853 in Q1 2025).
• System Placements: In Q1 2026, the company placed 431 da Vinci surgical systems. Of these, 232 were the newer da Vinci 5 systems, up from 147 placed in Q1 2025.

🚀 Company Investments and Capital Actions 💵

Beyond operational results, the company actively managed its capital and structure during the quarter. This highlights management's commitment to returning value to shareholders.

👉 During Q1 2026, Intuitive purchased 2.3 million shares of its common stock, spending a total of $1.1 billion. This share repurchase program is a common way for companies to return excess cash to investors.

🔮 2026 Financial Outlook and Guidance 🚀

Management provided specific guidance for the full year of 2026, giving investors a forward-looking roadmap of what to expect.

👉 The company expects worldwide da Vinci procedure growth to fall in a range of approximately 13.5% to 15.5% for the full year.

Margin and Expense Targets

• Gross Profit Margin: Non-GAAP gross profit margin is expected to be between 67.5% and 68.5% of revenue. This range accounts for an estimated 1.0% of revenue impact from current tariffs.
• Operating Expense Growth: Non-GAAP operating expenses are projected to grow by 11% to 14% in 2026.

⚠️ Risk Warning: Management emphasized that the outlook is sensitive to external factors, particularly tariffs. They stated that if additional tariffs beyond the current expectations are implemented, the financial results and expected margin could be materially impacted.

🗣️ Management Commentary and Future Focus ✨

Dave Rosa, the CEO, provided a statement summarizing the quarter and reaffirming the company's strategic focus.

"We are pleased with company performance this quarter, which was marked by expanded adoption of our da Vinci, Ion, and digital platforms,” said Dave Rosa, Intuitive CEO. “We remain deeply committed to supporting customers globally in their pursuit of the quintuple aim: achieving better patient outcomes, improving patient and care team experiences, lowering the total cost to treat, and expanding access to high quality, minimally invasive care.”

👉 The emphasis on the "quintuple aim" shows that the company sees its role extending beyond just selling robots; it’s about improving the entire healthcare system.

🏦 Financial Health (Balance Sheet) 💎

The company’s balance sheet shows its overall financial stability and asset structure as of March 31, 2026.

👉 Total assets were reported at $20.111 billion, slightly down from $20.458 billion at the end of 2025. This decrease largely reflects the cash used for the stock buyback and other investments.

• Cash Position: The company ended the quarter with $7.979 billion in cash, cash equivalents, and investments.
• Assets: Key assets include $5.447 billion in property, plant, and equipment, and $1,595.6 billion in accounts receivable, net.

📉 Understanding Non-GAAP vs. GAAP 📚

A crucial section of this filing explains the difference between GAAP and Non-GAAP financial measures. These terms refer to two different ways of calculating financial results.

👉 GAAP (Generally Accepted Accounting Principles): This is the standard, mandated way companies must report their finances. It provides a conservative, standardized view of performance. 👉 Non-GAAP: The company uses this measure to "normalize" its financials, removing specific, non-recurring items (like share-based compensation or amortization of intangibles). Management argues this provides a clearer picture of the company's core operational performance.

🌐 Who and Where to Connect 📞

The filing provided several resources for investors to follow up on the results.

• Investor Relations: For more information, investors can contact the Investor Relations team at (408) 523-2161.
• Webcast/Conference Call: Intuitive held a teleconference on the announcement date, which was webcast live and recorded. Replays are available on the company's website at www.intuitive.com.

🧠 The Analogy

Think of a company's financial reports like comparing a car's official MPG rating (GAAP) versus the mileage a professional race car driver reports during a track day (Non-GAAP). Both are facts, but they are calculated using different assumptions—the official test (GAAP) is standardized and mandatory, while the track day (Non-GAAP) is tailored to highlight the engine's maximum, best-case potential.

🧩 Final Takeaway

Intuitive demonstrated strong growth in Q1 2026, driven by both its established da Vinci system and the fast-growing Ion system. The company remains committed to high-tech growth while also demonstrating strong capital return to shareholders through its $1.1 billion stock buyback.